Analytical Data
-
基因名
MSH2
- Application
-
别名
HNPCC; COCA1; FCC1; HNPCC1; Colon Cancer,Nonpolyposis Type 1; DNA mismatch repair protein Msh2
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P43246
-
表达区间
Asn535~Thr934
-
分子量
48/16kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MSH2 is a crucial protein involved in the DNA mismatch repair (MMR) system, playing a vital role in maintaining genomic stability by correcting base pair mismatches that occur during DNA replication. Mutations or malfunctions in the MSH2 gene can lead to microsatellite instability (MSI) and an increased risk of various cancers, especially colorectal cancer. Understanding MSH2 at the molecular level is essential for deciphering its function in DNA repair and its implications in tumorigenesis. Research on recombinant MSH2 proteins helps elucidate the protein's structure-function relationships and interactions with other components of the MMR pathway, including MSH3 and MLH1. By expressing and purifying MSH2 recombinant proteins, scientists can investigate their biochemical properties, such as conformational changes, binding affinity, and repair activity in vitro. This research not only enhances our understanding of MSH2's mechanism but also has potential clinical implications, paving the way for targeted therapies and diagnostic tools for MMR-deficient cancers. Consequently, ongoing studies on MSH2 recombinant proteins aim to provide insights that could contribute to cancer prevention and treatment strategies, making it a significant focus in cancer research and molecular biology.
